Discovery of small-molecule HIV-1 fusion and integrase inhibitors oleuropein and hydroxytyrosol: part II. integrase inhibition.

Department of Biochemistry, New York University School of Medicine, New York, NY 10016, USA.
Biochemical and Biophysical Research Communications (Impact Factor: 2.28). 04/2007; 354(4):879-84. DOI: 10.1016/j.bbrc.2007.01.058
Source: PubMed

ABSTRACT We report molecular modeling and functional confirmation of Ole and HT binding to HIV-1 integrase. Docking simulations identified two binding regions for Ole within the integrase active site. Region I encompasses the conserved D64-D116-E152 motif, while region II involves the flexible loop region formed by amino acid residues 140-149. HT, on the other hand, binds to region II. Both Ole and HT exhibit favorable interactions with important amino acid residues through strong H-bonding and van der Waals contacts, predicting integrase inhibition. To test and confirm modeling predictions, we examined the effect of Ole and HT on HIV-1 integrase activities including 3'-processing, strand transfer, and disintegration. Ole and HT exhibit dose-dependent inhibition on all three activities, with EC(50)s in the nanomolar range. These studies demonstrate that molecular modeling of target-ligand interaction coupled with structural-activity analysis should facilitate the design and identification of innovative integrase inhibitors and other therapeutics.

  • [Show abstract] [Hide abstract]
    ABSTRACT: To find novel compounds against H5N1, three series of known or novel small molecular polyphenols were synthesized and tested in vitro for anti-H5N1 activity. In addition, the preliminary structure-antiviral activity relationships were elaborated. The results showed that some small molecular polyphenols had better anti-H5N1 activity, and could serve as novel virus entry inhibitors against H5N1, likely targeting to HA2 protein. Noticeably, compound 4a showed the strongest activity against H5N1 among these compounds, and the molecular modeling analysis also suggested that this compound might target to HA2 protein. Therefore, compound 4a is well qualified to serve as a lead compound or scaffold for the further development of H5N1 entry inhibitor.
    Bioorganic & medicinal chemistry letters 04/2014; · 2.65 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: The use of the products derived from the olive tree on human health dates back centuries. In several civilizations, the olive tree had and still has a very strong cultural and religious symbolism. Notably, the official seal and emblem of the World Health Organization features the rod of Asclepius over a world map surrounded by olive tree branches, chosen as a symbol of peace and health. Recently, accumulating experimental, clinical and epidemiological data have provided support to the traditional beliefs of the beneficial effect provided by olive derivates. In particular, the polyphenols present in olive leaves, olives, virgin (unrefined) olive oil and olive mill waste are potent antioxidant and radical scavengers with anti-tumor and anti-inflammatory properties. Here, we review the positive impact on human health of oleuropein, the most prevalent polyphenol present in olives. In addition, we provide data collected in our laboratory on the role of oleuropein in counteracting lipid accumulation in a mouse model of non-alcoholic fatty liver disease.
    International Journal of Molecular Sciences 10/2014; 15(10):18508-18524. · 2.34 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Ebola is a severe viral disease that spreads in West Africa countries, whose a search of an effective Drug is a necessity. The VP30 protein is known as an essential activator of transcription for Ebola virus. In another, Oleuropein, Kaempferol, and Quercetin are a bio-active components, originally from several plants, and which are known by their ability of inhibiting viral transcription activators such HIV. In this context we tested in silico by molecular modeling the ability of these substrates to inhibit VP30 by Building in the active sites, and the application of new pharmaceutical compounds, although direct manipulation in vitro or in vivo is limited by the terms of Biosafety -it is reserved for laboratory level BSL-4 -which slow the search process. The Oleuropein, Kaempferol, and Quercetin components are linked with the active sites of VP30 with a free energy score estimated near -8Kacl / mol and an average distance of 1.8 angstrom. We conclude that Oleuropein, Kaempferol, and Quercetin components may be effective treatment for Ebola Virus and essentially Kaempferol which has very ambitious Pharmacodynamics and kinetic owners, the things that make the component to be a candidate to be an effective Drug. Other experimental studies in vitro and in vivo are required to confirm. RESUME: Ebola virus c'est une sévère maladie virale qui se propage dans les pays West d'Afrique, dont la recherche des Drug efficaces est une nécessité. La protéine VP30 est connue comme un activateur indispensable pour Ebola Virus. En outre Oleuropein, Kaempferol, et Quercetin sont des composants Bioactives de plusieurs végétaux, et qui sont connus par leur capacité inhibitrice des Activateurs de transcription viraux telle de VIH. Dans ce contexte nous testions par modélisation moléculaire in silico la capacité de ces substrats à inhiber la VP30 par Building dans les sites actifs, malgré que la manipulation directe in vitro ou in vivo est limité par les conditions de Biosécurité – dont elle est réservée pour laboratoire de niveau BSL-4 -ce qui retarde le processus de recherche. Les composants Oleuropein, Kaempferol, et Quercetin sont liés avec les sites actifs de VP30 avec un score d'énergie libre estimé près -8Kacl/mol, et une distance moyenne de 1.8 angström. Nous concluons que Oleuropein, Kaempferol, et Quercetin peuvent être des composants thérapeutiques efficaces pour Ebola Virus et essentiellement Kaempferol qui a des propriétaires pharmacodynamiques et cinétiques très ambitieux, les choses qui font le composant de se porter candidat pour être un Drug efficace, et que des confirmations in vitro et in vivo sont nécessaires.
    International Journal of Innovation and Applied Studies. 10/2014; 8(8):2028-9324.

Full-text (2 Sources)

Available from
Sep 6, 2014